EndoGastric Solutions

OverviewSuggest Edit

EndoGastric Solutions is a medical technology company that develops incisionless transoral procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease and other GI disorders. It designs and manufactures EsophyX for use in endoluminal, transoral tissue approximation, thickness placation, and ligation in the GI tract. Its EsophyX is also indicated for the treatment of symptomatic chronic gastroesophageal reflux disease in patients who require and respond to pharmacological therapy. 

TypePrivate
Founded2002
HQRedmond, WA, US
Websiteendogastricsolutions.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Sept 2021)74(-3%)
Cybersecurity ratingAMore

Key People/Management at EndoGastric Solutions

Skip Baldino

Skip Baldino

President and CEO, Director
Brent Ahrens

Brent Ahrens

Director
Michael Burke

Michael Burke

Chief Financial Officer
Darren Crow

Darren Crow

Vice President, R&D Operations
Michael Carusi

Michael Carusi

Director
Adrian Lobontiu

Adrian Lobontiu

Chief Medical Officer
Show more

EndoGastric Solutions Office Locations

EndoGastric Solutions has offices in Redmond and San Mateo
Redmond, WA, US (HQ)
18109 NE 76th St #100
San Mateo, CA, US
1900 O'Farrell St #325
Show all (2)

EndoGastric Solutions Financials and Metrics

Summary Metrics

Founding Date

2002

EndoGastric Solutions total Funding

$312.3 m

EndoGastric Solutions latest funding size

$14.5 m

Time since last funding

2 years ago

EndoGastric Solutions investors

EndoGastric Solutions's latest funding round in May 2019 was reported to be $14.5 m. In total, EndoGastric Solutions has raised $312.3 m
Show all financial metrics

EndoGastric Solutions Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

EndoGastric Solutions Online and Social Media Presence

Embed Graph

EndoGastric Solutions News and Updates

United States Anti-Reflux Devices Markets Report, 2019-2025 Featuring Torax Medical, EndoGastric Solutions, Mederi Therapeutics & Medigus

DUBLIN, March 28, 2019 /PRNewswire/ -- The "Anti-Reflux Devices Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering. The value of the anti-reflux device market increased in 2018, and strong growth is expected to continue over the forecast...

EndoGastric Solutions Blogs

GERDHelp™ Mobile App to Assist GERD Patients in Navigating Their Journey With Individualized Education and Support, Provided by EndoGastric Solutions®

– Developed in partnership with DoctorPlan®, the app utilizes data to connect patients with expert clinicians as they jointly develop individualized plans for GERD treatment – REDMOND, Wash – June 23, 2021 – EndoGastric Solutions® today released the GERDHelp™ mobile application that will virtually g…

Preservatives: Uses, Benefits, and Risks

What Are Preservatives and Should I Be Avoiding Them? Preservatives are substances, both natural and artificial, that are added to a variety of goods in order to prevent premature decomposition and to prolong their shelf life. It is common to find preservatives in a large variety of foods and cosmet…

How to Get Exercise at Work

7 Ways to Incorporate Exercise Into Your Workday Exercise is generally good for you. While this isn’t a particularly enlightening or radical statement, it’s an important concept to keep in mind as we go about our day-to-day routines. Exercise can help you achieve an energy boost, improve your mood, …

H2 Blocker Medication Options for GERD

An Overview of H2 Receptor Antagonists for Reflux Histamine type 2 receptor antagonists —  also known as H2 blockers — are used to treat gastroesophageal reflux disease (GERD) and ulcers. Up to 60% of the US population experiences pain and discomfort from acid reflux. GERD symptoms may commonly incl…

PPI Medication Options for GERD

Proton Pump Inhibitors for Treating Reflux Gastroesophageal reflux disease (GERD) is a digestive disease that occurs when the stomach’s contents return back up into the esophagus. Carrying stomach acid or bile, the contents of the stomach irritate the esophagus’ lining. Symptoms of the disease inclu…

New Publication on TIF 2.0 in Therapeutic Advances in Gastroenterology Provides a Roadmap as Surgeons and Gastroenterologists Partner to Use the Procedure to Achieve Optimal Outcomes for Patients with Gastroesophageal Reflux Disease (GERD)

Continued evolution of EndoGastric Solutions’ EsophyX technology and concomitant use of TIF 2.0 with hiatal hernia repair brings long-term GERD relief to a broader spectrum of patients REDMOND, Wash – June 17, 2020 – EndoGastric Solutions® today announced the publication of a new review article in T…
Show more

EndoGastric Solutions Frequently Asked Questions

  • When was EndoGastric Solutions founded?

    EndoGastric Solutions was founded in 2002.

  • Who are EndoGastric Solutions key executives?

    EndoGastric Solutions's key executives are Skip Baldino, Brent Ahrens and Michael Burke.

  • How many employees does EndoGastric Solutions have?

    EndoGastric Solutions has 74 employees.

  • Who are EndoGastric Solutions competitors?

    Competitors of EndoGastric Solutions include Restech, Sekisui Diagnostics and HemoCue.

  • Where is EndoGastric Solutions headquarters?

    EndoGastric Solutions headquarters is located at 18109 NE 76th St #100, Redmond.

  • Where are EndoGastric Solutions offices?

    EndoGastric Solutions has offices in Redmond and San Mateo.

  • How many offices does EndoGastric Solutions have?

    EndoGastric Solutions has 2 offices.